Chromocell Therapeutics Corporation (CHRO)

Chromocell Therapeutics Statistics

Total Valuation

CHRO has a market cap or net worth of $3.98 million. The enterprise value is $5.01 million.

Market Cap	3.98M
Enterprise Value	5.01M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

CHRO has 6.03 million shares outstanding. The number of shares has increased by 333.40% in one year.

Current Share Class	6.03M
Shares Outstanding	6.03M
Shares Change (YoY)	+333.40%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	20.34%
Owned by Institutions (%)	2.14%
Float	1.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.60

Current Ratio	0.60
Quick Ratio	0.35
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-11.48

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-556.33%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.26M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.70
200-Day Moving Average	n/a
Relative Strength Index (RSI)	50.45
Average Volume (20 Days)	46,409

Short Selling Information

The latest short interest is 21,834, so 0.36% of the outstanding shares have been sold short.

Short Interest	21,834
Short Previous Month	3,343
Short % of Shares Out	0.36%
Short % of Float	1.38%
Short Ratio (days to cover)	0.74

Income Statement

Revenue	n/a
Gross Profit	-2.58M
Operating Income	-9.63M
Pretax Income	-8.98M
Net Income	-10.07M
EBITDA	n/a
EBIT	-9.63M
Earnings Per Share (EPS)	-$2.20

Balance Sheet

The company has $1.25 million in cash and $2.29 million in debt, giving a net cash position of -$1.03 million or -$0.17 per share.

Cash & Cash Equivalents	1.25M
Total Debt	2.29M
Net Cash	-1.03M
Net Cash Per Share	-$0.17
Equity (Book Value)	-1.43M
Book Value Per Share	-0.25
Working Capital	-1.43M

Cash Flow

Operating Cash Flow	-5.48M
Capital Expenditures	n/a
Free Cash Flow	-5.48M
FCF Per Share	-$0.91

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CHRO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-333.40%
Shareholder Yield	-333.40%
Earnings Yield	-253.05%
FCF Yield	-137.72%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2